When you hear the word tobacco, chances are you think of cigarettes, chewing tobacco, or ailing public health.
However, thanks to an early-stage biotechnology firm backed by big tobacco companies such as, Philip Morris International Inc., this association may soon change. This Québec-based biotechnology firm, Medicago, uses the Australian tobacco strain Nicotiana benthamiana to manufacture H1N1 flu vaccines.
You may be saying, big deal, I get a flu vaccine every year. However, what sets Medicago’s technology apart is.....
Read more on TechLi: http://tech.li/2011/11/future-flu-vaccine-tobacco/
